IRLCX | VITSX | IRLCX / VITSX | |
Total Expense Ratio | 0.61 | 0.03 | 2,033% |
Annual Report Gross Expense Ratio | 0.65 | 0.03 | 2,167% |
Fund Existence | 17 years | 28 years | - |
Gain YTD | -0.749 | 1.365 | -55% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 892M | 1.82T | 0% |
Annual Yield % from dividends | 1.58 | 1.29 | 122% |
Returns for 1 year | 8.43 | 10.06 | 84% |
Returns for 3 years | 66.64 | 57.62 | 116% |
Returns for 5 years | 89.31 | 91.41 | 98% |
Returns for 10 years | 187.94 | 179.47 | 105% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DLY | 15.66 | -0.03 | -0.22% |
DoubleLine Yield Opportunities Fund | |||
EMMF | 28.27 | -0.35 | -1.21% |
WisdomTree Emerging Markets Mltfctr | |||
FEP | 46.99 | -0.59 | -1.24% |
First Trust Europe AlphaDEX® ETF | |||
EDV | 65.21 | -1.05 | -1.58% |
Vanguard Extended Duration Trs ETF | |||
HEAL | 10.58 | -0.19 | -1.76% |
Global X HealthTech ETF |